Education: Doctor of Pharmacy, Massachusetts College of Pharmacy and Health Services, Worcester
Residencies: PGY1, Lahey Hospital and Medical Center; PGY2, Rhode Island Hospital - University of Rhode Island PGY2 Ambulatory Care Program
Practice/Research Interests: Direct patient care and medication management of ambulatory patients, pharmacy education, transitions of care
Riester M, McAuliffe L, Collins C, Zullo A. Development and validation of the Tool for Pharmacists to Predict 30-day hospital readmission in patients with Heart Failure (ToPP-HF), AJHP;2021;78(18):1691–1700.
Mogul A, Corsi, K and McAuliffe L. Baricitinib: The Second FDA-Approved JAK Inhibitor for the Treatment of Rheumatoid Arthritis. Annals of Pharmacotherapy. 2019.
McAuliffe [Hunt] L, Zullo AR, Dapaah-Afriyie R, and Berard-Collins, C. Development and validation of a transitions-of-care pharmacist tool to predict potentially avoidable 30-day readmissions. AJHP. 2018;75(3):111-19.